At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.
Close
CMND Clearmind Medicine, Inc.
Not Yet Opened 01-09 16:00:00 EST
2.35
-0.08
-3.29%
盘后2.33
-0.02-0.85%
19:59 EST
High2.50
Low2.31
Vol41.18K
Open2.46
D1 Closing2.43
Amplitude7.74%
Mkt Cap3.52M
Tradable Cap2.93M
Total Shares1.50M
T/O96.88K
T/O Rate3.30%
Tradable Shares1.25M
P/B--
ROE--
EPS0.00
52wk High--
52wk Low--
P/E--
Dividend--
Div.Yield--
ROA--
Loading ...
Clearmind Medicine Says Nasdaq Compliance Regained on Minimum Bid Price Rule
Clearmind Medicine Kicks-off Patient Enrollment at Tel Aviv Sourasky Medical Center, Adding Another Site Activated in Its in Phase I/Iia Alcohol Use Disorder Trial
Clearmind Medicine Inc., a pre-clinical pharmaceutical company, develops novel psychedelic medicines to treat under-served health problems in Canada and internationally. It develops treatments for alcohol use disorders, binge drinking and eating disorders, as well as depression, binge eating, psychotherapy, mental health issues, and other binge behaviors. The company has a collaboration with Clearmind Medicine Inc. to conduct a study evaluating the companies combination treatment for obesity and metabolic syndrome. The company was formerly known as Cyntar Ventures Inc. and changed its name to Clearmind Medicine Inc. in March 2021. Clearmind Medicine Inc. was incorporated in 2017 and is based in Vancouver, Canada.